NCT07176975 2026-02-27
A Study to Test How Well Different Doses of BI 1831169 in Combination With an Anti-PD1 Antibody Are Tolerated in Japanese People With Different Advanced Cancers
Boehringer Ingelheim
Phase 1 Not yet recruiting
Clinical Trials
4 trialsNCT07395258 2026-02-09
A Study to Test Different Doses of BI 3923948 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors)
Boehringer Ingelheim
Phase 1 Not yet recruiting
NCT06933524 2025-10-01
ATB-320-001A
Autotelicbio
Phase 1 Not yet recruiting
NCT06553846 2024-08-14
A Clinial Trial of Lutetium [177Lu]-FAP-75 for the Treatment of Patients With Advanced Solid Tumors
Fudan University
Phase 1 Not yet recruiting